Transmembrane Glycoprotein

Transmembrane glycoproteins are important components of cell membranes and are characterized by oligosaccharide chains covalently linked to polypeptide chains. Glycosylation sites are mainly located in their extracellular regions, achieved by N-linked glycosylation (linked to asparagine residues) or O-linked glycosylation (linked to serine or threonine residues). Sugar chains not only provide structural stability to proteins but also confer functional specificity. Many transmembrane glycoproteins are receptors, such as G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs). Most （clusters of differentiation）CD molecules are also transmembrane glycoproteins expressed on the surface of antigen-presenting cells^[1]^[2].

References:

[1]. L Franco, et al. The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger cyclic ADP-ribose across membranes. FASEB J. 1998 Nov;12(14):1507-20. [Content Brief]

[2]. Kumi Oshima, et al. SHPS-1, a multifunctional transmembrane glycoprotein. FEBS Lett. 2002 May 22;519(1-3):1-7. [Content Brief]

Transmembrane Glycoprotein 関連製品 (368):

By Effects:	Inhibitors (229) Agonists (7) Ligands (14) Antagonists (7) Activators (10) Modulators (5)

製品番号	製品名	製品効果	純度	構造式

HY-P991908

Anti-CD86 Antibody (3D1)
Anti-CD86 Antibody (3D1) is an antibody against human CD86. Recommend Isotype Controls:?Mouse IgG2b kappa, Isotype Control (HY-P99982).

HY-185098

PD1-PDL1-IN-4	Inhibitor
PD1-PDL1-IN-4 (compound 19) is a potent and orally active PD1-PDL1 inhibitor that modulates TIGIT and PD-1 signalling pathways. PD1-PDL1-IN-4 can rescue CD8⁺ T cell and mouse splenocyte proliferation. PD1-PDL1-IN-4 inhibits tumor growth in a CT26 syngeneic colon adenocarcinoma mouse model. PD1-PDL1-IN-4 can be used for research on colon cancer.

HY-126800

Glycotriosyl glutamine
Glycotriosyl glutamine is a synthetic analogue of the Glycopeptide. Glycotriosyl glutamine induces focal glomerulonephritis (FGN) and the appearance of myeloid bodies in the epithelial cells of the podocytes in rats with nephritogenic activity.

HY-P991431

Anti-CD133/PROM1 Antibody (CMab-43)	Inhibitor
Anti-CD133/PROM1 Antibody (CMab-43) is a human IgG2a monoclonal antibody (mAb) targeting PROM1/CD133. Anti-CD133/PROM1 Antibody (CMab-43) can be used in colon cancer research.

HY-P992216

Anti-CD99 Antibody
Anti-CD99 Antibody is a monoclonal antibody that targets CD99. It can be used in ELISA, FACS, and functional assays. For isotype controls of Anti-CD99 Antibody, please refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P992021

WM-A1-3389	Inhibitor
WM-A1-3389 is an anti-human IGSF1monoclonal antibody and tumor growth inhibitor. WM-A1-3389 specifically binds to the C-terminus of IGSF1, increases secretion of Granzyme B, IFN?γ, and TNF?α, and inhibits growth of colon cancer or biliary tract cancer in xenogeneic or allogeneic mouse implantation models. WM-A1-3389 can be used for the research of colon cancer, biliary tract cancer, and head and neck cancer.

HY-P991296

JCAR-023	Inhibitor
JCAR-023 is a human monoclonal antibody (mAb) targeting CAML1/CD171. JCAR-023 can be used in Neuroblastoma research.

HY-P990280

Anti-Mouse CD27 Antibody (RM27-3E5)	Inhibitor
Anti-Mouse CD27 Antibody (RM27-3E5) is an agonistic rat-derived IgG2a κ type antibody, targeting to mouse CD27. Anti-Mouse CD27 Antibody (RM27-3E5) stimulates CD 27. Anti-Mouse CD27 Antibody (RM27-3E5) can be used for the researches of cancer and immunology, such as B16cOVA tumor.

HY-P992430

OI-3	Inhibitor
OI-3 is a monoclonal antibody targeting CD146 (MCAM). OI-3 specifically binds to CD146 on the surface of human mesothelioma cells and undergoes endocytosis; both chimeric (chOI-3) and murine (mOI-3) variants possess this activity. When conjugated with ²¹²Pb to form ²¹²Pb-TCMC-OI-3, OI-3 acts as a cytotoxic agent that delivers α-emitting radionuclides to induce targeted cytotoxicity. OI-3 can be used in research related to malignant peritoneal mesothelioma.

HY-P992005

DS-1055a	Inhibitor
DS-1055a is an anti-human GARP antibody. DS-1055a effectively depletes GARP-positive regulatory T cells in the tumor microenvironment, and activates effector T cells. DS-1055a exhibits antitumor activity and can be used for the research of cancer, such as colon cancer.

HY-P991620

JS006	Inhibitor
JS006 is a humanized IgG4κ monoclonal antibody inhibitor targeting TIGIT/CD155. JS006 can be used to study advanced and/or metastatic cancers with resistance to PD-1/PD-L1 inhibitor such as non-small cell lung cancer (NSCLC), advanced lymphoma and advanced/metastatic triple negative breast cancer (TNBC) .

HY-148543

FC-99	Inhibitor
FC-99 is a Tenascin-C (TN-C) inhibitor with anti-inflammatory effects. FC-99 reduces inflammatory responses in rheumatoid arthritis (RA). FC-99 is promising for research of autoimmune diseases, particularly rheumatoid arthritis.

HY-P991759

Anti-Rat CD86 Antibody (OX-48)	Inhibitor
Anti-Rat CD86 Antibody (OX-48) recognizes CD86, thereby blocking the binding of CD86 to CD28, and thus inhibiting T cell proliferation. Recommend Isotype Controls: Mouse IgG1 kappa, Isotype Control (HY-P99977).

HY-P11799

cLABL	Ligand
cLABL is a cyclic peptide that specifically binds to ICAM‑1. cLABL mediates targeted enrichment and rapid endocytosis of nanoparticles. cLABL is applicable to researches such as precise drug delivery at inflammatory sites.

HY-P990357

Anti-CD69 Antibody	Inhibitor
Anti-CD69 Antibody is a human-derived antibody expressed in CHO, targeting CD69. The predicted molecular weight (MW) of Anti-CD69 Antibody is 150 kDa. The isotype control for Anti-CD69 Antibody can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P992016

Anti-NRG1 Antibody	Inhibitor
Anti-NRG1 Antibody is an anti-NRG1 antibody. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P991817

Anti-Mouse CD318 Antibody (9a2)	Inhibitor
Anti-Mouse CD318 Antibody (9a2) reacts with the mouse that selectively recognized native CD318 protein on both human and mouse cell surfaces in flow cytometry assays.

HY-P992344

DNP002	Inhibitor
DNP002 is a humanized IgG1 monoclonal antibody targeting tumor-associated CEACAM6. DNP002 binds to CEACAM1, CEACAM5 and CEACAM6, and exhibits antibody-dependent cellular cytotoxicity against tumor cells overexpressing these targets. DNP002 binds to CEACAM6 on the surface of tumor-associated neutrophils (including MDSCs) to reverse the immunosuppressive effect in the tumor microenvironment. DNP002 shows anti-tumor activity in advanced solid tumors. DNP002 can be used for the research of advanced solid tumors. The recommended isotype control is human IgG1 kappa (HY-P99001).

HY-P992223

Anti-DAG1/Dystroglycan Antibody (DAG-6F4)
Anti-DAG1/Dystroglycan Antibody (DAG-6F4) is a human monoclonal antibody against DAG1/Dystroglycan. Anti-DAG1/Dystroglycan Antibody (DAG-6F4) can bind specifically to the α and β subunits of the dystroglycan protein complex. Anti-DAG1/Dystroglycan Antibody (DAG-6F4) is applicable to research related to muscular dystrophy.

HY-P991661

AMG-172 Antibody
AMG-172 Antibody is an anti-CD27L antibody. AMG-172 Antibody can be used for synthesis of ADC AMG-172 (HY-185483).

お名前
メール *

	Sorry, but the email address you supplied was invalid.